Clinical Trial Results: Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating obeticholic acid (OCA) in combination with an additional agent (BZF) for primary biliary cholangitis; study completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• BZF
• Obeticholic acid (obeticholic acid)

Snippet

Sponsor: Intercept Pharmaceuticals | Conditions: Primary Biliary Cholangitis | Phase 2 | Status: COMPLETED | Results posted: 2026-07-16